| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 77.19× | 77.19× | 71.08× | 44.41× | 24.68× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 7.98× | 7.93× | 8.31× | 3.57× | 2.44× | ||
| 0.32× | 0.32× | 0.22× | 0.20× | 0.19× | ||
| 2.56× | 2.56× | −1.85× | −36.16× | 1.36× | ||
| 0.65× | 0.65× | 15.24× | 1.00× | 1.45× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 24.68 | 44.41 | 71.08 | 77.19 | 77.19 | |
| Working Capital Turnover | 2.44 | 3.57 | 8.31 | 7.93 | 7.98 | |
| Asset Turnover | 0.19 | 0.20 | 0.22 | 0.32 | 0.32 | |
| Cash Conversion (CFO/Net Income) | 1.36 | -36.16 | -1.85 | 2.56 | 2.56 | |
| CFO/EBITDA | 1.45 | 1.00 | 15.24 | 0.65 | 0.65 |